Effect of Guanxindanshen Dropping Pills on Quality of Life and Cardiovascular Prognosis of Patients with Depression or Anxiety after PCI for Coronary Heart Disease
- Conditions
- Depression or Anxiety after PCI for CHD
- Registration Number
- ITMCTR1900002368
- Lead Sponsor
- Xiyuan Hospital, CACMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1) Voluntarily participate in the trial and sign the ICF;
2) To meet the diagnostic criteria of CHD and complete PCI;
3) PHQ-9 score 5-14, or GAD-7 score 5-14;
4) Aged 18-75 years old, male or female;
5) Be able to cooperate with examination and treatment.
1) wicked liquid condition;
2) Unalleviated angina attack or NYHA cardiac function grade IV;
3) electrolyte disorder, acid-base imbalance;
4) Complicated with pulmonary, liver, kidney, hematopoietic system, immune system and other serious primary diseases and dysfunction;
5) Organic mental disorders, depression caused by other mental disorders such as schizophrenia or somatic diseases etc.;
6) Bipolar disorder, rapid circulatory seizures;
7) History of epilepsy;
8) Alcohol or drug abuse and drug addicts within one year;
9) Other antidepressants and antianxiety drugs were taken within four weeks before the trial;
10) Pregnant or lactating women or planned pregnancies;
11) Those who have participated in clinical trials of other drugs within 3 months;
12) Researchers do not consider it appropriate to participate in clinical trials;
13) Suicide-prone patients.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PHQ-9 scale;GAD-7 scale;SAQ;
- Secondary Outcome Measures
Name Time Method SF-12 scale;Initial time and incident rate of MACE;